Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.

@article{Kotlyar2011EffectOO,
  title={Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.},
  author={Michael E. Kotlyar and Louise A Hertsgaard and Bruce R. Lindgren and Joni A Jensen and Steven G. Carmella and Irina Stepanov and Sharon E Murphy and Stephen S Hecht and Dorothy K. Hatsukami},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  year={2011},
  volume={20 1},
  pages={91-100}
}
BACKGROUND Smokeless, spitless tobacco products are being introduced and marketed as cigarette substitutes. Data are needed regarding how smokers interested in cessation would use these products, the levels of resultant toxicant exposure, and the feasibility of using these products as aids for tobacco cessation. METHODS Smokers were randomized to receive Camel Snus (n = 51), Taboka (n = 52), or medicinal nicotine (n = 27) and required to quit smoking for 4 weeks. Measures of toxicant exposure… CONTINUE READING
6 Citations
34 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Similar Papers

Loading similar papers…